Ignite Creation Date:
2024-05-06 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03659136
Status:
COMPLETED
Last Update Posted:
2024-07-10
First Post:
2018-09-03
Brief Title:
The XENERA 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-28
Start Date Type:
ACTUAL
Primary Completion Date:
2021-08-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05-11
Completion Date Type:
ACTUAL
First Submit Date:
2018-09-03
First Submit QC Date:
September 3 2018
Study First Post Date:
2018-09-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-09-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-17
Last Update Post Date:
2024-07-10
Last Update Post Date Type:
ACTUAL